Press Releases

Recent & Archived News

November 14, 2019

Bayer and Dewpoint Therapeutics partner to research new treatments for cardiovascular and gynecological diseases

Bayer and Dewpoint Therapeutics, a biotechnology company with sites in Boston and Dresden, Germany, today announced an option, research and license agreement worth up to USD 100 million. The...

Learn more
November 13, 2019

Make Velum and Movento the Choice for Orchard Solutions

As one of the greatest hazards to almond orchards, nematodes can negatively impact root health. According to the California Department of Food and Agriculture, nematodes can cause up to a 50...

Learn more
November 12, 2019

Ten nonprofit organizations received a total of $50,000 through the Bayer Cereal Experts Grain for Good Program for second year

For the second year in a row, ten cereals growers each directed a $5,000 donation to a nonprofit organization of their choice as part of the Bayer Cereal Experts Grain for Good™ Sweepstakes. The...

Learn more
November 07, 2019

Bayer invests $50 Million in eGenesis Series B financing round

eGenesis, a biotechnology company utilizing breakthrough gene editing technologies for the development of effective human-compatible organs to address the global organ shortage, successfully...

Learn more
November 06, 2019

Ten nonprofit organizations received a total of $50,000 through the Bayer Farm for Good Program

Ten row crop growers each directed a $5,000 donation to a nonprofit organization of their choice as part of the Bayer Farm for Good™ Sweepstakes. The $50,000 in donations will help provide...

Learn more
November 05, 2019

Luna Fungicide Scores Top Marks Against Powdery Mildew and Botrytis

As the most common fungi in orchards and vineyards, powdery mildew and Botrytis both thrive in climates where grapes are grown. The Luna® family of fungicides from Bayer continues to offer...

Learn more
October 21, 2019

Bayer Submits Supplemental New Drug Application to FDA for Intrauterine Device (IUD) Mirena® (levonorgestrel-releasing intrauterine system) 52 mg

Bayer, a leader in women's healthcare, announced today the submission of a supplemental new drug application (sNDA) to the U.S. Food and Drug Administration (FDA) to potentially extend the...

Learn more
October 21, 2019

CRISPR Therapeutics and Bayer Announce an Update on Casebia Therapeutics

CRISPR Therapeutics and Bayer today announced proposed plans whereby Casebia Therapeutics, a joint venture between CRISPR Therapeutics and Bayer, would operate under the direct management of...

Learn more
October 21, 2019

Bayer Announces Recipients of the Pulmonary Hypertension Accelerated Bayer (PHAB) Awards at CHEST Annual Meeting 2019

Bayer today announced recipients of the inaugural Pulmonary Hypertension Accelerated Bayer (PHAB) Awards, a U.S.-based research grant program created to support clinical research in pulmonary...

Learn more
October 16, 2019

Employees Roll Up Their Sleeves and Give Back for Bayer's Third Annual Community Service Day

Bayer employees nationwide will spend the day giving back to the communities across the United States where they live, work and play. As part of Bayer's longstanding commitment to corporate...

Learn more

 

Want even more Bayer news?

Check out our Social Media & Blogs.